Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
2018 · Theranostics · 103 citations
https://doi.org/10.7150/thno.23177
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
187
Citations
3
h-index
3
i10-index
Jiang-Kai Dong is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related gene regulation & Cancer, Hypoxia, and Metabolism. The author has an h-index of 3, co-authored 13 publications.
Click to start Chat